UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.
Search Articles
Cochrane Database of Systematic Reviews, ISSN 1469-493X, 10/2016, Volume 2016, Issue 10, pp. CD001347 - CD001347
Osteoporosis | Glucocorticoids | Diphosphonates | Bone Density Conservation Agents | Spinal Fractures | Rheumatology | Osteoporosis [premenopausal, post‐menopausal, corticosteroid induced, osteoporosis in men ] | Treatment [pharmacological agents] | Pharmacological therapies | Medicine General & Introductory Medical Sciences | Bisphosphonates | Randomized Controlled Trials as Topic | Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Spinal Fractures - prevention & control | Osteoporosis - chemically induced | Osteoporosis - prevention & control | Humans | Bone Density Conservation Agents - therapeutic use | Diphosphonates - therapeutic use | Adult | Glucocorticoids - adverse effects | Index Medicus
Journal Article
Respiratory medicine, ISSN 0954-6111, 2006, Volume 101, Issue 1, pp. 177 - 185
Pulmonary/Respiratory | Vertebral fractures | Pulmonary function | Secondary osteoporosis | Corticosteroid induced osteoporosis | COPD | Cardiac & Cardiovascular Systems | Respiratory System | Life Sciences & Biomedicine | Cardiovascular System & Cardiology | Science & Technology | Osteoporosis. Osteomalacia. Paget disease | Pharmacology. Drug treatments | Bones, joints and connective tissue. Antiinflammatory agents | Diseases of the osteoarticular system | Biological and medical sciences | Injuries of the limb. Injuries of the spine | Medical sciences | Traumas. Diseases due to physical agents | Chronic obstructive pulmonary disease, asthma | Pneumology | Spirometry | Bone Density | Prevalence | Cross-Sectional Studies | Humans | Middle Aged | Male | Pulmonary Disease, Chronic Obstructive - physiopathology | Pulmonary Disease, Chronic Obstructive - complications | Bone Diseases, Metabolic - complications | Osteoporosis - complications | Fractures, Bone - complications | Fractures, Bone - physiopathology | Female | Aged | Bone Diseases, Metabolic - physiopathology | Osteoporosis - physiopathology | Osteoporosis | Medical research | Care and treatment | Lung diseases, Obstructive | Medicine, Experimental | Development and progression | Prevalence studies (Epidemiology) | Bones | Bone density | Disease | Older people | Index Medicus
Journal Article
Cochrane Database of Systematic Reviews, ISSN 1465-1858, 2011, Volume 2011, Issue 7, pp. CD000333 - CD000333
Bone Density | Rheumatology | Fractures, Bone | Non‐pharmacological therapies | Randomized Controlled Trials as Topic | Prevention | Osteoporosis | Exercise | Osteoporosis, Postmenopausal | Osteoporosis [premenopausal, post‐menopausal, corticosteroid induced, osteoporosis in men ] | Treatment [non‐pharmacological] | Rehabilitation | Medicine General & Introductory Medical Sciences | Bone Density - physiology | Humans | Female | Exercise - physiology | Osteoporosis, Postmenopausal - therapy | Fractures, Bone - therapy | Osteoporosis, Postmenopausal - prevention & control | Fractures, Bone - prevention & control | Index Medicus
Journal Article
Cochrane Database of Systematic Reviews, ISSN 1469-493X, 2014, Volume 2014, Issue 3, pp. CD005467 - CD005467
Osteoporosis | Drugs, Chinese Herbal | Complementary & alternative medicine | Bone Density Conservation Agents | Rheumatology | Osteoporosis [premenopausal, post‐menopausal, corticosteroid induced, osteoporosis in men ] | Treatment [non‐pharmacological] | Herbal | Non‐pharmacological therapies | Phytotherapy | Medicine General & Introductory Medical Sciences | Randomized Controlled Trials as Topic | Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Bone Density Conservation Agents - therapeutic use | Osteoporosis - drug therapy | Phytotherapy - methods | Drugs, Chinese Herbal - therapeutic use | Humans | Index Medicus
Journal Article
Cochrane Database of Systematic Reviews, ISSN 1469-493X, 2007, Volume 2010, Issue 7, pp. CD005324 - CD005324
Osteoporosis | Bone Density | Diphosphonates | Bone Density Conservation Agents | Child health | Rheumatology | Osteoporosis [premenopausal, post‐menopausal, corticosteroid induced, osteoporosis in men ] | Treatment [pharmacological agents] | Controlled Clinical Trials as Topic | Pharmacological therapies | Medicine General & Introductory Medical Sciences | Bisphosphonates | Bone density conservation agents [adverse effects; therapeutic use] | Diphosphonates [adverse effects; therapeutic use] | Bone density [drug effects] | Controlled clinical trials as topic | Adolescent | Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Bone Density - drug effects | Bone Density Conservation Agents - adverse effects | Osteoporosis - prevention & control | Humans | Bone Density Conservation Agents - therapeutic use | Diphosphonates - therapeutic use | Osteoporosis - drug therapy | Child | Diphosphonates - adverse effects | Index Medicus
Journal Article
The lancet. Diabetes & endocrinology, ISSN 2213-8587, 06/2018, Volume 6, Issue 6, pp. 445 - 454
UNITED-STATES | CONTROLLED-TRIAL | FRACTURE | MANAGEMENT | THERAPY | INHIBITION | PREVENTION | PREVALENCE | CORTICOSTEROID-INDUCED OSTEOPOROSIS | POSTMENOPAUSAL WOMEN | ALENDRONATE | INDUCED BONE LOSS | Life Sciences & Biomedicine | Endocrinology & Metabolism | Science & Technology | Risedronic Acid - therapeutic use | Double-Blind Method | Osteoporosis - prevention & control | Humans | Middle Aged | Osteoporotic Fractures - prevention & control | Male | Denosumab - therapeutic use | Bone Density - drug effects | Risedronic Acid - pharmacology | Female | Aged | Denosumab - pharmacology | Glucocorticoids - adverse effects | Risedronate | Osteoporosis | Dosage and administration | Denosumab | Comparative analysis | Drug therapy | Index Medicus
Journal Article